chrX-137566825-ACGC-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP3BP6BS2
The NM_003413.4(ZIC3):c.159_161del(p.Ala55del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,155,920 control chromosomes in the GnomAD database, including 1 homozygotes. There are 149 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., 8 hem., cov: 24)
Exomes 𝑓: 0.00033 ( 1 hom. 141 hem. )
Consequence
ZIC3
NM_003413.4 inframe_deletion
NM_003413.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.41
Genes affected
ZIC3 (HGNC:12874): (Zic family member 3) This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. This nuclear protein probably functions as a transcription factor in early stages of left-right body axis formation. Mutations in this gene cause X-linked visceral heterotaxy, which includes congenital heart disease and left-right axis defects in organs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_003413.4
BP6
Variant X-137566825-ACGC-A is Benign according to our data. Variant chrX-137566825-ACGC-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 573248.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}. Variant chrX-137566825-ACGC-A is described in Lovd as [Likely_benign]. Variant chrX-137566825-ACGC-A is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAd4 at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZIC3 | NM_003413.4 | c.159_161del | p.Ala55del | inframe_deletion | 1/3 | ENST00000287538.10 | |
ZIC3 | NM_001330661.1 | c.159_161del | p.Ala55del | inframe_deletion | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZIC3 | ENST00000287538.10 | c.159_161del | p.Ala55del | inframe_deletion | 1/3 | 1 | NM_003413.4 | P1 | |
ZIC3 | ENST00000370606.3 | c.159_161del | p.Ala55del | inframe_deletion | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000143 AC: 16AN: 111747Hom.: 0 Cov.: 24 AF XY: 0.000205 AC XY: 7AN XY: 34143
GnomAD3 genomes
AF:
AC:
16
AN:
111747
Hom.:
Cov.:
24
AF XY:
AC XY:
7
AN XY:
34143
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00104 AC: 100AN: 96477Hom.: 0 AF XY: 0.000982 AC XY: 32AN XY: 32583
GnomAD3 exomes
AF:
AC:
100
AN:
96477
Hom.:
AF XY:
AC XY:
32
AN XY:
32583
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000330 AC: 345AN: 1044131Hom.: 1 AF XY: 0.000417 AC XY: 141AN XY: 338231
GnomAD4 exome
AF:
AC:
345
AN:
1044131
Hom.:
AF XY:
AC XY:
141
AN XY:
338231
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000152 AC: 17AN: 111789Hom.: 0 Cov.: 24 AF XY: 0.000234 AC XY: 8AN XY: 34195
GnomAD4 genome
AF:
AC:
17
AN:
111789
Hom.:
Cov.:
24
AF XY:
AC XY:
8
AN XY:
34195
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Heterotaxy, visceral, 1, X-linked Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 06, 2018 | Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acid is currently unknown. This variant has not been reported in the literature in individuals with ZIC3-related disease. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant, c.159_161delCGC, results in the deletion of 1 amino acid(s) of the ZIC3 protein (p.Ala55del), but otherwise preserves the integrity of the reading frame. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
ZIC3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 24, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at